Rheum Round-up: Are CBD Products Safe?, and much more

The use of cannabis products and those containing cannabidiol (CBD) are becoming increasingly popular, with people turning to them as possible treatments for pain, including pain caused by chronic illness. However, whether products are advertised as containing Δ9-tetrahydrocannabinol (THC) or CBD may not always be accurate, a study suggests.

“People are buying products they think are THC-free but in fact contain a significant amount of THC,” explained lead study author Jodi M. Gilman, PhD. “One patient reported that she took a product she thought only contained CBD, and then when driving home that day she felt intoxicated, disoriented and very scared.”

A study observed differences in the risk of new-onset dementia by gender and age among statin users with rheumatoid arthritis (RA).

Statin use was not correlated with the risk of new-onset dementia in the overall study population, but in subgroup analyses, statin use appeared to have a protective effect for certain patients with RA. Patients aged ≥60 years who were statin users, compared to non-statin users, had a lower risk of dementia. Also among patients aged ≥60 years, male statin users were less likely than female patients to develop dementia.

Finally, a study found that the Quit Connect protocol in rheumatology clinics is feasible and increases electronic referrals to a state-run tobacco quit line. “Rheumatology visits provide a unique opportunity to address smoking as a chronic modifiable risk factor in populations at high risk for cardiovascular disease, pulmonary disease, and rheumatic disease progression,” the authors write.


In Case You Missed It:

‘CBD-Dominant’ Products May Actually Contain THC

Statin Use May Decrease Dementia Risk in Certain Patients with RA

Protocol Ups Referrals to Tobacco Quit Line in Rheumatology Clinics